The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tessmer James F since 2012.
This trader's CIK number is 1434095.
At the time of last reporting, Tessmer James F was the VP, Finance & Accounting of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX).
Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | LXRX | 0 | $0 | 22,912 | $158,436 | 40,316 | $39,720 |
| 2019 | LXRX | 10,000 | $11,399 | 0 | $0 | 10,226 | $0 |
| 2018 | LXRX | 0 | $0 | 10,000 | $129,080 | 17,353 | $101,500 |
| 2017 | LXRX | 0 | $0 | 0 | $0 | 6,939 | $0 |
| 2016 | LXRX | 0 | $0 | 7,500 | $100,500 | 13,328 | $46,725 |
| 2015 | LXRX | 0 | $0 | 0 | $0 | 29,625 | $0 |
| 2014 | LXRX | 0 | $0 | 0 | $0 | 20,250 | $0 |
| 2013 | LXRX | 0 | $0 | 0 | $0 | 27,450 | $0 |
| 2012 | LXRX | 0 | $0 | 0 | $0 | 7,500 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-15 | LXRX | Option Ex | 12,000 | 3.31 | 39,720 |
| 2021-03-15 | LXRX | Sale | 22,912 | 6.92 | 158,436 |
| 2021-02-28 | LXRX | Option Ex | 28,316 | .00 | 0 |
| 2019-08-02 | LXRX | Buy | 10,000 | 1.14 | 11,399 |
| 2019-02-28 | LXRX | Option Ex | 10,226 | .00 | 0 |
| 2018-06-08 | LXRX | Option Ex | 10,000 | 10.15 | 101,500 |
| 2018-06-08 | LXRX | Sale | 10,000 | 12.91 | 129,080 |
| 2018-02-28 | LXRX | Option Ex | 7,353 | .00 | 0 |
| 2017-02-28 | LXRX | Option Ex | 6,939 | .00 | 0 |
| 2016-06-06 | LXRX | Sale | 1,500 | 15.00 | 22,500 |
| 2016-06-06 | LXRX | Option Ex | 1,500 | 6.23 | 9,345 |
| 2016-05-23 | LXRX | Option Ex | 6,000 | 6.23 | 37,380 |
| 2016-05-23 | LXRX | Sale | 6,000 | 13.00 | 78,000 |
| 2016-02-29 | LXRX | Option Ex | 5,828 | .00 | 0 |
| 2015-03-02 | LXRX | Option Ex | 29,625 | .00 | 0 |
| 2014-02-28 | LXRX | Option Ex | 20,250 | .00 | 0 |
| 2013-02-28 | LXRX | Option Ex | 14,250 | .00 | 0 |
| 2013-01-31 | LXRX | Option Ex | 13,200 | .00 | 0 |
| 2012-02-28 | LXRX | Option Ex | 7,500 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tessmer James F (VP, Finance & Accounting of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.